Page last updated: 2024-10-28

hydroxychloroquine and Complications, Hematologic Pregnancy

hydroxychloroquine has been researched along with Complications, Hematologic Pregnancy in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Pregnancy seems to increase the risk of thrombotic thrombocytopenic purpura (TTP) relapses and make the TTP more severe in any of the pregnancy trimesters, or even during the postpartum period."1.62A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report. ( Afrooz, N; Aminimoghaddam, S; Mahmoudzadeh, F; Motaghi Nejad, O; Nasiri, S, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aminimoghaddam, S1
Afrooz, N1
Nasiri, S1
Motaghi Nejad, O1
Mahmoudzadeh, F1
Greenberg, AE1
Kloser, P1
Deloron, P1
Williams, SB1

Other Studies

2 other studies available for hydroxychloroquine and Complications, Hematologic Pregnancy

ArticleYear
A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: a case report.
    Journal of medical case reports, 2021, Mar-01, Volume: 15, Issue:1

    Topics: Acute Kidney Injury; Amphetamine-Related Disorders; Antiviral Agents; COVID-19; Drug Combinations; E

2021
Assessment of possible drug-resistant Plasmodium falciparum in a pregnant traveller with sickle cell disease.
    Lancet (London, England), 1987, Feb-21, Volume: 1, Issue:8530

    Topics: Adult; Anemia, Sickle Cell; Drug Resistance, Microbial; Female; Humans; Hydroxychloroquine; Infant,

1987